199 related articles for article (PubMed ID: 10632639)
21. Acute interstitial nephritis due to mesalazine.
Tadic M; Grgurevic I; Scukanec-Spoljar M; Bozic B; Marusic S; Horvatic I; Galesic K
Nephrology (Carlton); 2005 Apr; 10(2):103-5. PubMed ID: 15877665
[TBL] [Abstract][Full Text] [Related]
22. Interstitial nephritis from mesalazine: case report and literature review.
Arend LJ; Springate JE
Pediatr Nephrol; 2004 May; 19(5):550-3. PubMed ID: 15007714
[TBL] [Abstract][Full Text] [Related]
23. Mesalazine-induced interstitial nephritis in a patient with ulcerative colitis.
Gorospe EC; Leggett CL
BMJ Case Rep; 2012 Feb; 2012():. PubMed ID: 22665567
[No Abstract] [Full Text] [Related]
24. 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.
Van Staa TP; Travis S; Leufkens HG; Logan RF
Gastroenterology; 2004 Jun; 126(7):1733-9. PubMed ID: 15188168
[TBL] [Abstract][Full Text] [Related]
25. [Interstitial nephritis associated with mesalazine therapy].
Vuotila M; Ikäheimo R; Pietiläinen T
Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
[No Abstract] [Full Text] [Related]
26. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.
Fraser JS; Muller AF; Smith DJ; Newman DJ; Lamb EJ
Aliment Pharmacol Ther; 2001 Aug; 15(8):1131-7. PubMed ID: 11472315
[TBL] [Abstract][Full Text] [Related]
27. Renal effects of long-term treatment with 5-aminosalicylic acid.
Patel H; Barr A; Jeejeebhoy KN
Can J Gastroenterol; 2009 Mar; 23(3):170-6. PubMed ID: 19319380
[TBL] [Abstract][Full Text] [Related]
28. Pediatric case of mesalazine-induced interstitial nephritis with literature review.
Co ML; Gorospe EC
Pediatr Int; 2013 Jun; 55(3):385-7. PubMed ID: 23782372
[TBL] [Abstract][Full Text] [Related]
29. Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event.
Magalhães-Costa P; Matos L; Chagas C
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25935912
[TBL] [Abstract][Full Text] [Related]
30. Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.
Haas M; Shetye KR
Am J Kidney Dis; 2001 Jul; 38(1):205-9. PubMed ID: 11431204
[No Abstract] [Full Text] [Related]
31. Mesalazine induced interstitial nephritis.
Thuluvath PJ; Ninkovic M; Calam J; Anderson M
Gut; 1994 Oct; 35(10):1493-6. PubMed ID: 7959212
[TBL] [Abstract][Full Text] [Related]
32. Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine.
Margetts PJ; Churchill DN; Alexopoulou I
J Clin Gastroenterol; 2001 Feb; 32(2):176-8. PubMed ID: 11205659
[TBL] [Abstract][Full Text] [Related]
33. Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease.
Mulder CJ; van den Hazel SJ
Mediators Inflamm; 1998; 7(3):135-6. PubMed ID: 9705596
[TBL] [Abstract][Full Text] [Related]
34. The pharmacological profile and clinical use of mesalazine (5-aminosalicylic acid).
Klotz U
Arzneimittelforschung; 2012 Feb; 62(2):53-8. PubMed ID: 22344548
[TBL] [Abstract][Full Text] [Related]
35. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.
Heap GA; So K; Weedon M; Edney N; Bewshea C; Singh A; Annese V; Beckly J; Buurman D; Chaudhary R; Cole AT; Cooper SC; Creed T; Cummings F; de Boer NK; D'Inca R; D'Souza R; Daneshmend TK; Delaney M; Dhar A; Direkze N; Dunckley P; Gaya DR; Gearry R; Gore S; Halfvarson J; Hart A; Hawkey CJ; Hoentjen F; Iqbal T; Irving P; Lal S; Lawrance I; Lees CW; Lockett M; Mann S; Mansfield J; Mowat C; Mulgrew CJ; Muller F; Murray C; Oram R; Orchard T; Parkes M; Phillips R; Pollok R; Radford-Smith G; Sebastian S; Sen S; Shirazi T; Silverberg M; Solomon L; Sturniolo GC; Thomas M; Tremelling M; Tsianos EV; Watts D; Weaver S; Weersma RK; Wesley E; Holden A; Ahmad T
J Crohns Colitis; 2016 Feb; 10(2):149-58. PubMed ID: 26619893
[TBL] [Abstract][Full Text] [Related]
36. How safe are the safest IBD drugs?
Lewis JD
Gastroenterology; 2003 Jun; 124(7):1986-7; discussion 1987-8. PubMed ID: 12806636
[No Abstract] [Full Text] [Related]
37. Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease.
Druez A; Rahier JF; Hébuterne X
J Crohns Colitis; 2014 Aug; 8(8):900-1. PubMed ID: 24486176
[No Abstract] [Full Text] [Related]
38. Late onset interstitial nephritis associated with mesalazine treatment.
Popoola J; Muller AF; Pollock L; O'Donnell P; Carmichael P; Stevens P
BMJ; 1998 Sep; 317(7161):795-7. PubMed ID: 9740571
[No Abstract] [Full Text] [Related]
39. [Nephrogenic diabetes insipidus secondary to chronic interstitial nephritis associated with mesalazine therapy].
García-Martín F; Sánchez Heras M; Sánchez Martínez L; Rodríguez-Zapata M
Rev Clin Esp; 2002 Apr; 202(4):245-6. PubMed ID: 12003743
[No Abstract] [Full Text] [Related]
40. Interstitial nephritis in children with Crohn's disease.
Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V
Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
